MICHELE EVANS-REAVIS: Open Payments
NPI 1760804546 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 45 payments from 14 companies in 2025. Trend: 2023 $2,719 · 2024 $2,331 · 2025 $1,299
Food & beverage: $1,299
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 4 | $359 |
| AstraZeneca Pharmaceuticals LP | 12 | $209 |
| MERZ NORTH AMERICA, INC. | 1 | $136 |
| GENZYME CORPORATION | 6 | $127 |
| GlaxoSmithKline, LLC. | 4 | $87 |
| HARMONY BIOSCIENCES LLC | 3 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $64 |
| JAZZ PHARMACEUTICALS INC. | 3 | $56 |
| Lilly USA, LLC | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
Products named: INSPIRE, DUPIXENT, AIRSUPRA, NUCALA, TEZSPIRE, WAKIX, GLASSIA, XYWAV.
Industry payments across VA — which companies pay providers there.
